HCM II Acquisition Corp. is a dynamic special purpose acquisition company (SPAC) focused on identifying and merging with high-growth entities within the healthcare sector. Led by an adept management team with deep industry expertise, the firm leverages strategic alliances to pinpoint and capitalize on lucrative investment opportunities in innovative healthcare businesses. By concentrating on emerging trends and transformative solutions, HCM II seeks to facilitate institutional investors' access to the evolving healthcare landscape, offering potential for significant value creation in their investment portfolios.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | 0.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.48 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $25.00M |
| Float | $21.05M |
| % Insiders | 0.00% |
| % Institutions | 0.17% |
Volatility is currently contracting